Degarelix and its therapeutic potential in the treatment of prostate cancer
Christian Doehn, Martin Sommerauer, Dieter JochamDepartment of Urology, University of Lübeck Medical School, Lübeck, GermanyAbstract: Degarelix is a gonadotropin-releasing hormone (GnRH) antagonist for the treatment of patients with prostate cancer in whom hormonal therapy is indicated. Tw...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2009-05-01
|
| Edice: | Clinical Interventions in Aging |
| Témata: | |
| On-line přístup: | https://www.dovepress.com/degarelix-and-its-therapeutic-potential-in-the-treatment-of-prostate-c-peer-reviewed-article-CIA |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|